Insulin Resistance Intervention After Stroke Trial
Trial ID or NCT#
NCT00091949
Status
NOT RECRUITING
Purpose
The purpose of this study is to determine if pioglitazone is effective in preventing future strokes or heart attacks among non-diabetic persons who have had a recent ischemic stroke.
Official Title
Insulin Resistance Intervention After Stroke (IRIS) Trial
Eligibility Criteria
Ages Eligible for Study: Older than 40 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Investigator(s)
Maarten Lansberg, MD, PhD
Stroke and vascular neurologist,
General neurologist
Professor of Neurology (Adult Neurology) and, by courtesy, of Neurosurgery
Anna Finley Caulfield, MD
Neurocritical care specialist
Clinical Professor, Neurology & Neurological Sciences
Chitra Venkatasubramanian, MBBS, MD, MSc, FNCS
Stroke and vascular neurologist,
Neurocritical care specialist
Clinical Professor, Neurology & Neurological Sciences
Clinical Professor (By courtesy), Neurosurgery
Gregory W. Albers, MD
Stroke and vascular neurologist
Coyote Foundation Professor and Professor, by courtesy, of Neurosurgery
Contact us to find out if this trial is right for you.
Contact
Madelleine Garcia
6507252326
View on ClinicalTrials.gov
